Andrea Sambati
Directeur Général chez Boehringer Ingelheim (Canada) Ltd.
Profil
Andrea Sambati is associated with two firms, Boehringer Ingelheim (Canada) Ltd.
and Boehringer Ingelheim Animal Health Canada, Inc. She is currently the President & Chief Executive Officer at Boehringer Ingelheim (Canada) Ltd.
and also holds the position of Secretary & Director at Boehringer Ingelheim Animal Health Canada, Inc.
Postes actifs de Andrea Sambati
| Sociétés | Poste | Début |
|---|---|---|
Boehringer Ingelheim (Canada) Ltd.
 Boehringer Ingelheim (Canada) Ltd. BiotechnologyHealth Technology Boehringer Ingelheim (Canada) Ltd. engages in the research and development of new drugs and medicines for the treatment of respiratory diseases. The firm offers therapeutic options for diseases and conditions, such as chronic obstructive pulmonary disease, high blood pressure, stroke, depression, benign prostatic hyperplasia, Parkinson's disease, virology, stroke prevention in atrial fibrillation, and diabetes. The company was founded in 1972 and is headquartered in Burlington, Canada. | Directeur Général | - |
Boehringer Ingelheim Animal Health Canada, Inc.
 Boehringer Ingelheim Animal Health Canada, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Animal Health Canada, Inc. provides disease prevention and health management in animals. The firm offers pharmaceutical products and vaccines for livestock, pets, and wildlife. The company is headquartered in Baie-d'Urfé, Canada. | Directeur Général | 01/08/2019 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Boehringer Ingelheim (Canada) Ltd.
Boehringer Ingelheim (Canada) Ltd. BiotechnologyHealth Technology Boehringer Ingelheim (Canada) Ltd. engages in the research and development of new drugs and medicines for the treatment of respiratory diseases. The firm offers therapeutic options for diseases and conditions, such as chronic obstructive pulmonary disease, high blood pressure, stroke, depression, benign prostatic hyperplasia, Parkinson's disease, virology, stroke prevention in atrial fibrillation, and diabetes. The company was founded in 1972 and is headquartered in Burlington, Canada. | Health Technology |
Boehringer Ingelheim Animal Health Canada, Inc.
Boehringer Ingelheim Animal Health Canada, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Animal Health Canada, Inc. provides disease prevention and health management in animals. The firm offers pharmaceutical products and vaccines for livestock, pets, and wildlife. The company is headquartered in Baie-d'Urfé, Canada. | Health Technology |
